The Astrocytic GABAA/Benzodiazepine-Like Receptor: Identifying the Joker Receptor for Benzodiazepine-Mimetic Drugs?
Book:
Frontiers in CNS Drug Discovery
Page:
342-361
Author(s):
Leif Hertz and Ye Chen
Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia Disorders
Book:
Frontiers in CNS Drug Discovery
Page:
304-341
Author(s):
Christa E. Muller and Sergi Ferre
Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia
Book:
Frontiers in CNS Drug Discovery
Page:
284-303
Author(s):
Kenji Hashimoto
Glucocorticoids Involvement in the Control of CNS Excitability: An Updated
Book:
Frontiers in CNS Drug Discovery
Page:
245-283
Author(s):
Anna Capasso, Mariella Caputo, Mario Felice Tecce and Alberto Loizzo
Antiepileptic Drug and Estradiol Neuroprotection in Epilepsy
Book:
Frontiers in CNS Drug Discovery
Page:
224-244
Author(s):
Libor Velisek and Jana Veliskova
Drugs and Aggression†
Book:
Frontiers in CNS Drug Discovery
Page:
206-223
Author(s):
Alberto A. Rasia-Filho, Marcia Giovenardi and Rosa M.M. de Almeida
Recent Developments in Anxiety Disorders
Book:
Frontiers in CNS Drug Discovery
Page:
184-205
Author(s):
David M. Christmas, Geetha Menon and Sean D. Hood
Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
Book:
Frontiers in CNS Drug Discovery
Page:
156-183
Author(s):
Karine Fabio, Christophe Guillon, Shi-fang Lu, Ned D. Heindel, Marvin Miller, Craig F. Ferris, Michael J. Brownstein and Carrie Gar
Pharmacological Treatment for Parkinson's Disease: A Continuing Evolution
Book:
Frontiers in CNS Drug Discovery
Page:
147-155
Author(s):
Quincy J. Almeida and H. Christopher Hyson
Alzheimer's Disease Drug Discovery: Potential Therapeutic Strategies and Future Treatments
Book:
Frontiers in CNS Drug Discovery
Page:
123-146
Author(s):
Laurent Lecanu and Vassilios Papadopoulos